help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirwan, L. D.
Right arrow Articles by Goodman, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirwan, L. D.
Right arrow Articles by Goodman, J. M.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 4 1618-1629
Copyright © 2004 by The Endocrine Society

Acute and Chronic Effects of Hormone Replacement Therapy on the Cardiovascular System in Healthy Postmenopausal Women

Lori D. Kirwan, Neil J. MacLusky, Heather M. Shapiro, Beth L. Abramson, Scott G. Thomas and Jack M. Goodman

Faculty of Physical Education and Health (L.D.K., S.G.T., J.M.G.), Department of Obstetrics and Gynecology (H.M.S.), Cardiac Prevention Centre and Women’s Cardiovascular Health, St. Michael’s Hospital (B.L.A.), University of Toronto, Toronto, Ontario M5S 2W6, Canada; and Department of Obstetrics and Gynecology, Columbia University Medical School (N.J.M.), New York, New York 10032

Address all correspondence and requests for reprints to: Dr. Jack M. Goodman, Ph.D., Faculty of Physical Education and Health, University of Toronto, 55 Harbord Street, Toronto, Ontario M5S 2W6, Canada. E-mail: jack.goodman{at}utoronto.ca.

Previous studies have shown that conjugated estrogens and continuous medroxyprogesterone increases heart disease risk in healthy women. Little is known about the effects of the natural ovarian hormones estradiol and progesterone on cardiovascular function at rest and exercise. The purpose of this study was to investigate the short- and longer-term effects of a cyclic format of hormone replacement therapy (HRT) (1 mg estradiol daily with cyclic micronized progesterone, 200 mg for 10 d/month) on cardiovascular function at rest and during exercise in healthy, postmenopausal women. A double-blind, cross-over study was conducted in 31 patients. Peak oxygen uptake and ventilatory threshold in addition to submaximal cardiac output were determined. Peripheral measures of resting and peak ischemic blood flows were also determined. Measurements were made at baseline, after 4 h of estrogen/placebo exposure, and subsequently after 1, 2, and 3 months. The sequence of data collection was repeated after 6-wk washout. Oral estradiol with cyclic micronized progesterone increases peak ischemic peripheral blood flow chronically but fails to improve exercise tolerance and peak oxygen uptake. Similarly, submaximal central cardiovascular function is unaffected by HRT. This suggests that estradiol has a beneficial effect on peripheral blood flow, but this benefit offers little advantage in terms of peak exercise performance after 3 months of HRT.

This work was supported by the Heart and Stroke Foundation of Ontario Grant NA3367.

Abbreviations: avO2 diff, Arteriovenous oxygen difference; BF, blood flow; CAD, coronary artery disease; ERT, estrogen replacement therapy; G, vascular conductance; HRT, hormone replacement therapy; MAP, mean arterial pressure; MP, micronized progesterone; Q, cardiac output; SV, stroke volume; VCO2, ventilatory equivalent for carbon dioxide; VO2, oxygen uptake; VO2peak, peak oxygen consumption; VT, ventilatory threshold.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Oneda, C. L. M. Forjaz, F. R. Bernardo, T. G. Araujo, J. L. Gusmao, E. Labes, S. B. Abrahao, D. Mion Jr., A. M. Fonseca, and T. Tinucci
Low-dose estrogen therapy does not change postexercise hypotension, sympathetic nerve activity reduction, and vasodilation in healthy postmenopausal women
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1802 - H1808.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Loyer, T. Damy, Z. Chvojkova, E. Robidel, F. Marotte, P. Oliviero, C. Heymes, and J.-L. Samuel
17{beta}-Estradiol Regulates Constitutive Nitric Oxide Synthase Expression Differentially in the Myocardium in Response to Pressure Overload
Endocrinology, October 1, 2007; 148(10): 4579 - 4584.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society